U.S., Feb. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07392580) titled 'Intralesional Chemotherapy (IC): Cisplatin + Epinephrine' on Jan. 30.
Brief Summary: The purpose of this study is to determine the effects, good and bad, of injecting chemotherapy into recurrent laryngeal squamous cell carcinoma (SCC) tumors.
Study Start Date: April 01
Study Type: INTERVENTIONAL
Condition:
Laryngeal Squamous Cell Carcinoma
Intervention:
DRUG: Cisplatin
Participants will be administered 1 mg/mL Cisplatin via intralesional injection in combination with Epinephrine injection therapy. Total treatment volume will determined by the volume of the tumor to be injected.
DRUG: Epinephrine injection
Participants will b...